Model
Edge
Alnylam Pharmaceuticals, Inc.
0001557290
Filing type
3
Filing date
Jan 6, 2026
Updated
Jan 7, 2026 ยท 2:16 PM
Copy reference
Filing
3
Initial Statement of Beneficial Ownership